A novel splice site FUS mutation in a familial ALS case: effects on protein expression

References

• van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet Lond Engl. 2017;390:2084–98.
   PubMed Web of Science ®Google Scholar
• Renton AE, Chiò A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.
   PubMed Web of Science ®Google Scholar
• Birsa N, Bentham MP, Fratta P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin Cell Dev Biol. 2020;99:193–201.
   PubMed Web of Science ®Google Scholar
• Cook C, Petrucelli L. Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron*. 2019;101:1057–69.
   PubMed Web of Science ®Google Scholar
• Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33:855–76.
   PubMed Web of Science ®Google Scholar
• An H, Skelt L, Notaro A, Highley JR, Fox AH, La Bella V, et al. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol Commun. 2019;7:7.
   PubMed Web of Science ®Google Scholar
• Armstrong GAB, Drapeau P. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet. 2013;22:4282–92.
   PubMed Web of Science ®Google Scholar
• Chiò A, Calvo A, Mazzini L, Cantello R, Mora G, Moglia C, PARALS, et al. Extensive genetics of ALS: a population-based study in Italy. Neurology 2012;79:1983–9.
   PubMed Web of Science ®Google Scholar
• Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in Genie. J Comput Biol. 1997;4:311–23.
   PubMed Web of Science ®Google Scholar
• Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell 2019;176:535–48.e24.
   PubMed Web of Science ®Google Scholar
• De Marco G, Lupino E, Calvo A, Moglia C, Buccinnà B, Grifoni S, et al. Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol. 2011;121:611–22.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–8.
   PubMed Web of Science ®Google Scholar
• De Marco G, Lomartire A, Calvo A, Risso A, De Luca E, Mostert M, et al. Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distribution. Neuropathol Appl Neurobiol. 2017;43:133–53.
   PubMed Web of Science ®Google Scholar
• Belzil VV, St-Onge J, Daoud H, Desjarlais A, Bouchard J-P, Dupré N, et al. Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis. J Hum Genet. 2011;56:247–9.
   PubMed Web of Science ®Google Scholar
• An H, Rabesahala de Meritens C, Buchman VL, Shelkovnikova TA. Frameshift peptides alter the properties of truncated FUS proteins in ALS-FUS. Mol Brain. 2020;13:77.
   PubMed Web of Science ®Google Scholar
• Lagier-Tourenne C, Cleveland DW. Rethinking ALS: the FUS about TDP-43. Cell 2009;136:1001–4.
   PubMed Web of Science ®Google Scholar
• Law WJ, Cann KL, Hicks GG. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic. 2006;5:8–14.
   PubMedGoogle Scholar
• Ishigaki S, Sobue G. Importance of functional loss of FUS in FTLD/ALS. Front Mol Biosci. 2018;5:44.
   PubMed Web of Science ®Google Scholar
• Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009;323:1208–11.
   PubMed Web of Science ®Google Scholar
• Verbeeck C, Deng Q, Dejesus-Hernandez M, Taylor G, Ceballos-Diaz C, Kocerha J, et al. Expression of fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol Neurodegener. 2012;7:53.
   PubMed Web of Science ®Google Scholar
• Nickless A, Bailis JM, You Z. Control of gene expression through the nonsense-mediated RNA decay pathway. Cell Biosci. 2017;7:26.
   PubMed Web of Science ®Google Scholar
• Amrani N, Sachs MS, Jacobson A. Early nonsense: mRNA decay solves a translational problem. Nat Rev Mol Cell Biol. 2006;7:415–25.
   PubMed Web of Science ®Google Scholar
• Bai J, Qu Y, Cao Y, Yang L, Ge L, Jin Y, et al. The SMN1 common variant c.22 dupA in Chinese patients causes spinal muscular atrophy by nonsense-mediated mRNA decay in humans. Gene 2018;644:49–55.
   PubMed Web of Science ®Google Scholar
• Brichta L, Garbes L, Jedrzejowska M, Grellscheid S-N, Holker I, Zimmermann K, et al. Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy. Hum Genet. 2008;123:141–53.
   PubMed Web of Science ®Google Scholar
• Qu Y-J, Ge L, Bai J-L, Cao Y-Y, Jin Y-W, Wang H, et al. p.Val19Glyfs*21 and p.Leu228* variants in the survival of motor neuron 1 trigger nonsense-mediated mRNA decay causing the SMN1 PTC + transcripts degradation. Mutat Res. 2017;806:31–8.
   PubMed Web of Science ®Google Scholar
• Groen EJN, Fumoto K, Blokhuis AM, Engelen-Lee J, Zhou Y, van den Heuvel DMA, et al. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum Mol Genet. 2013;22:3690–704.
   PubMed Web of Science ®Google Scholar
• Sun S, Ling S-C, Qiu J, Albuquerque CP, Zhou Y, Tokunaga S, et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat Commun. 2015;6:6171.
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Chen S, Yu Y, Yan B, Haertlein TC, Carrasco MA, et al. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2012;2:799–806.
   PubMed Web of Science ®Google Scholar